Pure Global

Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants - Trial NCT04936477

Access comprehensive clinical trial information for NCT04936477 through Pure Global AI's free database. This phase not specified trial is sponsored by King's College London and is currently Not yet recruiting. The study focuses on Bronchopulmonary Dysplasia. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT04936477
Not yet recruiting
other
Trial Details
ClinicalTrials.gov • NCT04936477
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants
Functional Morphometry and Ventilation Perfusion Ratio to Estimate the Alveolar Surface Area in Prematurely Born Infants

Study Focus

Calculation of ventilation-perfusion ratio

Interventional

other

Sponsor & Location

King's College London

London, United Kingdom

Timeline & Enrollment

N/A

Sep 29, 2020

Aug 31, 2022

30 participants

Primary Outcome

Calculation of the alveolar surface area in prematurely born infants using validated functional morphometry

Summary

To non-invasively estimate the alveolar surface area of the lungs of prematurely born infants
 by taking measurements of oxygen and carbon dioxide and utilizing functional morphometry.

ICD-10 Classifications

Bronchopulmonary dysplasia originating in the perinatal period
Congenital bronchomalacia
Bronchopneumonia, unspecified
Other congenital malformations of bronchus
Diseases of bronchus, not elsewhere classified

Data Source

ClinicalTrials.gov

NCT04936477

Non-Device Trial